Top Story

FDA approves Viekira Pak for treatment of HCV

December 19, 2014

The FDA today approved a treatment for patients with hepatitis C virus genotype 1 infection, including those with cirrhosis, according to a press release.

A combination of ombitasvir, paritaprevir and ritonavir tablets with dasabuvir tablets (Viekira Pak, AbbVie) is the fourth chronic HCV drug product the FDA has approved in the past 14 months, and the 11th drug to have previously received the FDA’s breakthrough therapy designation. It can be used with or without ribavirin, but is not recommended for patients with decompensated cirrhosis.

Clinical setbacks integral to long-term success in HCV treatment

December 19, 2014
In a new report, the Pharmaceutical Research and Manufacturers of America examined the successes and failures of hepatitis C virus infection research and therapies since…
In the Journals

Cryptosporidiosis outbreak linked to calves involved in rollover accident

December 19, 2014
An outbreak of six cases of cryptosporidiosis was identified among emergency responders to a rollover accident involving a tractor-trailer carrying approximately 350…

CMS releases new quality of care data on physicians, ACOs, hospitals

December 19, 2014
CMS released new data on the quality of care provided by physician group practices, hospitals and Accountable Care Organizations, according to the CMS Blog.Included in…

CDC, FDA: Multistate listeriosis outbreak linked to caramel apples

December 19, 2014
The CDC and FDA announced an ongoing investigation of an outbreak of listeria infections associated with commercially produced, prepackaged caramel apples.As of Dec. 18…
More News Headlines »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME
HBV

Critical Issues in HBV
HBV Management in Complex Populations: Volume 1, Number 2

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »